ArticleBriefings in bioinformatics2026
Hierarchical Multi-Omics Trajectory Prediction for fecal microbiota transplantation: a novel machine learning framework for small-sample longitudinal multi-omics integration.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fecal microbiota transplantation (FMT) has emerged as a highly effective treatment for recurrent Clostridioides difficile infection and is being actively investigated for numerous other conditions. While multi-omics studies have revealed dynamic changes in microbial communities and host metabolism following FMT, existing approaches are primarily descriptive and lack the ability to model individual patient trajectories or identify early biomarkers of treatment response. Small-sample, multi-omics, longitudinal prediction presents unique computational challenges: high dimensionality ($p \gg n$), multi-omics integration, temporal dynamics, and interpretability. Here, we present Hierarchical Multi-Omics Trajectory Prediction (HMOTP), a purpose-built machine learning framework that addresses these challenges through hierarchical feature construction, multilevel attention mechanisms, and patient-specific trajectory prediction. We evaluated HMOTP on 15 patients with recurrent Clostridioides difficile infection who underwent FMT, with lipidomics and metagenomics profiling at four timepoints spanning 6 months. Notably, naively concatenating multi-omics features degraded Random Forest performance ($93.33\%$ to $87.18\%$ accuracy), whereas HMOTP's hierarchical integration benefited from the additional omics layer, demonstrating that its advantage stems from structure, not from access to more data. Through hierarchical interpretability, HMOTP identified key biomarkers and revealed cross-omics associations between host lipid metabolism and microbial energy pathways, demonstrating utility for longitudinal modeling and biological discovery in FMT response. HMOTP provides a generalizable, principled framework for personalized medicine applications across small-sample multi-omics problems. Source code and a demo dataset are publicly available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.